Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
354,64 B | 2,49% | 4/6 | 25,40% | -24,74% | 26,43% | DOWN |
|
Amgen NasdaqGS:AMGN |
186,69 B | 7,37% | 3/6 | 2,72% | -6,34% | 2,05% | UP |
|
Gilead Sciences NasdaqGS:GILD |
164,96 B | 3,30% | 5/6 | 4,53% | -50,58% | 20,77% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
41,19 B | 46,06% | 4/6 | 49,91% | 9,14% | 44,89% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
27,89 B | -10,57% | 1/6 | -1,25% | 1,40% | 9,70% | UP |
|
Incyte NasdaqGS:INCY |
19,25 B | 41,79% | 5/6 | 8,74% | 26,71% | 10,09% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,41 B | 12,22% | 5/6 | 45,50% | 61,20% | 73,59% | DOWN |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
10,35 B | 48,13% | 5/6 | -45,97% | -0,46% | 19,05% | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,54 B | 19,97% | 5/6 | 59,76% | -44,49% | 0,28% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,97 B | 0,00% | 0/4 | 0,00% | 0,00% | 190,51% | UP |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,79 B | 29,02% | 5/6 | 15,27% | -26,59% | 46,13% | DOWN |
|
Travere Therapeutics NasdaqGM:TVTX |
3,70 B | 10,07% | 5/6 | 42,67% | -97,93% | 23,47% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,17 B | 40,93% | 5/6 | 5,58% | 20,45% | 34,93% | UP |
|
Celldex Therapeutics NasdaqCM:CLDX |
2,68 B | -34,06% | 1/6 | 114,74% | -433,38% | 60,77% | UP |
